Neha Patil (Editor)

Gliquidone

Updated on
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Covid-19
Trade names  Glurenorm
Routes of administration  Oral (tablets)
Molar mass  527.634 g/mol
Pregnancy category  C
ATC code  A10BB08 (WHO)
CAS ID  33342-05-1
Gliquidone
AHFS/Drugs.com  International Drug Names
Legal status  UK: POM (Prescription only) In general: ℞ (Prescription only)

Gliquidone (INN, sold under the trade name Glurenorm) is an anti-diabetic medication in the sulfonylurea class. It is classified as a second-generation sulfonylurea. It is used in the treatment of diabetes mellitus type 2. It is marketed by the pharmaceutical company Boehringer Ingelheim (Germany).

Contents

Contraindications

  • Allergy to sulfonylureas or sulfonamides
  • Diabetes mellitus type 1
  • Diabetic ketoacidosis
  • Patients that underwent removal of the pancreas
  • Acute porphyria
  • Severe liver disease accompanying with liver insufficiency
  • Several conditions (e.g., infectious diseases or major surgical intervention), when insulin administration is required
  • Pregnancy or breastfeeding
  • Pharmacokinetics

    Gliquidone is fully metabolized by the liver. Its metabolites are excreted virtually completely with bile (even with long-term administration), thus allowing the use of medication in diabetic patients suffering from kidney disease and diabetic nephropathy.

    References

    Gliquidone Wikipedia


    Topics
     
    B
    i
    Link
    H2
    L